It was a busy week for the Contemporary OB/GYN® team.
This week's top articles included:
On Aug. 23, the U.S. Food and Drug Administration granted full approval to the Pfizer-BioNTech coronavirus vaccine, which is a significant milestone in the pandemic. It is the first licensing of a vaccine for the novel coronavirus.
The role of the community pharmacist has greatly expanded beyond traditional product-focused services to encompass a number of sexual and reproductive health (SRH) services, according to a review in BMJ Open.
A high-throughput molecular diagnostic system that is fully automated has won approval from the U.S. Food and Drug Administration and now is available in the U.S. market for cervical cancer screenings.
Alcohol and tobacco use throughout the first trimester of pregnancy was associated with nearly 3 times the risk of late stillbirth (at 28 or more weeks), compared to women who neither drank alcohol nor smoked during pregnancy or quit both before the end of the first trimester.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More